• Title/Summary/Keyword: essential drugs

Search Result 245, Processing Time 0.031 seconds

Studies on Essential Oils of Lycopus lucidus Turcz (택란(澤蘭)의 정유성분(精油成分)에 관한 연구(硏究))

  • Shin, Soon-Hee;Sim, Youn;Kim, You-Sun;Chi, Hyung-Joon;Lee, Eun-Bang
    • Korean Journal of Pharmacognosy
    • /
    • v.23 no.1
    • /
    • pp.29-33
    • /
    • 1992
  • The essential oils of Lycopus lucidus have been studied. The essential oil obtained from the dried herba by steam distillation followed by fractionation by column chromatography was analysed by gas chromatography-mass spectrometry(GC-MS). The compounds identified by GC-MS were carvacrol, 2,5-dimethoxy-p-cymene, trans-caryophyllene, spathurenol and $trans-{\beta}-farnesene$. Two compounds, thymol and caryophyllene were isolated by silica gel column chromatography and analyzed by TLC, IR, Mass and NMR. And the weak diuretic effects of essential oil and water extract from the dried drugs were observed in rats.

  • PDF

Pharmacogenomics in Drug Discovery and Development

  • Ahn, Chul
    • Genomics & Informatics
    • /
    • v.5 no.2
    • /
    • pp.41-45
    • /
    • 2007
  • Pharmacogenomics is the study that examines how genetic variations affect the ways in which people respond to drugs. The ways people respond to drugs are complex traits that are influenced by many different genes. Pharmacogenomics intends to develop rational means of optimizing drug therapy, with respect to the patients' genotype, to maximize efficacy with minimal adverse drug reactions. Pharmacogenomics has the potential to revolutionize the practice of medicine, and promises to usher in an area of personalized medicine, in which drugs and drug combinations are optimized for each individual's unique genetic makeup. Indeed, pharmacogenomics is exploited as an essential step for target discovery and drug development in the pharmaceutical industry. The goal of the personalized medicine is to get the right dose of the right drug to the right patient at the right time. In this article, we will review the use of pharmacogenomics in drug discovery and development.

Reflections on Sports for All Bodybuilding Participants and Doping

  • Sang-Hyun Lee
    • International Journal of Internet, Broadcasting and Communication
    • /
    • v.15 no.3
    • /
    • pp.160-165
    • /
    • 2023
  • Physical education bodybuilders compete by means of external appearance, and more and more people are starting bodybuilding with an interest in improving their individual constitution and diet. However, some of the bodybuilders in sports for life started using banned substances to show off their appearance or to expect good results in bodybuilding competitions. Prohibited drugs only have a short-term positive effect on the subject, and the seriousness of side effects was greater when taking the drug for a long time. An education program that can provide professional education and information on drugs to bodybuilding athletes for life sports should be preceded, and a system that can check regular health should be introduced if necessary. A periodic doping education program for bodybuilders for sport for life is needed to focus on the positive changes in bodybuilding through banned substances and to educate and understand the side effects and damage to life that occur later. Therefore, in order to prevent doping, it is essential to educate various aspects of doping, and it is required to expand the scope not only to elite athletes but also to participants as sports for all

Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development

  • Yujin Jin;Kyung-Sun Heo
    • The Korean Journal of Physiology and Pharmacology
    • /
    • v.27 no.4
    • /
    • pp.299-310
    • /
    • 2023
  • Non-alcoholic fatty liver disease (NAFLD) is a complex disorder characterized by the accumulation of fat in the liver in the absence of excessive alcohol consumption. It is one of the most common liver diseases worldwide, affecting approximately 25% of the global population. It is closely associated with obesity, type 2 diabetes, and metabolic syndrome. Moreover, NAFLD can progress to non-alcoholic steatohepatitis, which can cause liver cirrhosis, liver failure, and hepatocellular carcinoma. Currently, there are no approved drugs for the treatment of NAFLD. Therefore, the development of effective drugs is essential for NAFLD treatment. In this article, we discuss the experimental models and novel therapeutic targets for NAFLD. Additionally, we propose new strategies for the development of drugs for NAFLD.

Immunological Mechanisms in Cutaneous Adverse Drug Reactions

  • Ai-Young Lee
    • Biomolecules & Therapeutics
    • /
    • v.32 no.1
    • /
    • pp.1-12
    • /
    • 2024
  • Adverse drug reactions (ADRs) are an inherent aspect of drug use. While approximately 80% of ADRs are predictable, immune system-mediated ADRs, often unpredictable, are a noteworthy subset. Skin-related ADRs, in particular, are frequently unpredictable. However, the wide spectrum of skin manifestations poses a formidable diagnostic challenge. Comprehending the pathomechanisms underlying ADRs is essential for accurate diagnosis and effective management. The skin, being an active immune organ, plays a pivotal role in ADRs, although the precise cutaneous immunological mechanisms remain elusive. Fortunately, clinical manifestations of skin-related ADRs, irrespective of their severity, are frequently rooted in immunological processes. A comprehensive grasp of ADR morphology can aid in diagnosis. With the continuous development of new pharmaceuticals, it is noteworthy that certain drugs including immune checkpoint inhibitors have gained notoriety for their association with ADRs. This paper offers an overview of immunological mechanisms involved in cutaneous ADRs with a focus on clinical features and frequently implicated drugs.

Nonsteroidal Anti-inflammatory Drugs (비스테로이드 항염제)

  • Lee, Choong-Ki
    • Journal of Yeungnam Medical Science
    • /
    • v.17 no.1
    • /
    • pp.1-11
    • /
    • 2000
  • Inhibition of cyclooxygenase(COX), and thus prevention of the formation of prostaglandins, provided a unifying explanation of the therapeutic and toxic actions of nonsteroidal anti-inflammatory drugs (NSAIDs). Recently, the discovery of the two isoforms of COX was made by molecular biologists studying neoplastic transformation in chick embryo cells. The constitutive enzyme, COX-1, is obviously responsible for the production of prostaglandins involved in housekeeping functions such as maintenance of integrity of the gastric mucosa, renal blood flow and platelet aggregation. The inducible form of COX (COX-2) is responsible for the formation of prostaglandins that pathologically affects inflammation, pain and fever. Clearly, all the experimental and clinical data support the hypothesis that the beneficial effects of NSAIDs are due to inhibition of the COX-2 enzyme, whereas the gastrotoxicity is due to inhibition of COX-1. The cox-2/COX-1 ratios of the NSAIDs in common use have been measured and compared with epidemiological data on their side effects. There is little evidence to suggest that one NSAID is clearly more effective than another, But substantial individual variability is present with respect to the pharmacology and pharmacokinetics of these drugs: therefore it is essential to adjust the dosage and choose specific drug to the patient's response.

  • PDF

Activity of Essential Oil from Mentha piperita against Some Antibiotic-Resistant Streptococcus pneumoniae Strains and Its Combination Effects with Antibiotics

  • Choi, Sung-Hee;Shin, Seung-Won
    • Natural Product Sciences
    • /
    • v.13 no.2
    • /
    • pp.164-168
    • /
    • 2007
  • To investigate natural antibiotics from plant essential oils and to evaluate their synergism with current antimicrobial drugs in inhibiting antibiotic-resistant strains of Streptococcus pneumoniae. The minimal inhibitory concentrations (MICs) of eleven plant essential oils and their main components were established for two antibiotic-susceptible and two antibiotic-resistant strains of S. pneumoniae, using broth microdilution tests. Potential synergism with oxacillin, norfloxacin, or erythromycin was evaluated using a checkerboard microtitre assay. Among the tested oils, Mentha piperita oil and its main component, menthol, exhibited the strongest inhibitory activities against all of the tested strains. The activity of antibiotics against antibiotic-resistant strains of S. pneumoniae was enhanced significantly by combination with Mentha piperita oils and its main component, menthol. In conclusion, the combination Mentha piperita essential oil or menthol with antibiotics could be used to reduce the effective dose of antibiotic and to modulate the resistance of S. pneumoniae strains.

Differences in Neurotransmitters Level as Biomarker on Sleep Effects in Dementia Patients with Insomnia after Essential Oils Treatment

  • Kyung-Bok Lee;Sana Latif;Young-Sook Kang
    • Biomolecules & Therapeutics
    • /
    • v.31 no.3
    • /
    • pp.298-305
    • /
    • 2023
  • This study aimed to examine the effects of several essential oils on insomnia in dementia patients following transdermal treatment (aromatherapy). The mean change rates (%) of sleep biomarkers were compared between the single essential and jojoba (vehicle) oil massage groups in this study. The lavender (L) essential oil massage group demonstrated a significant decrease in the mean change rate (%) of 24-h urinary free cortisol, whereas the valerian (V) essential oil massage group demonstrated a significant increase in the mean change rate (%) of serum 5-hydroxytryptamine. In addition, a significant increase in the mean change rate (%) of 24-h urinary norepinephrine was observed in the chamomile (C) essential oil massage group only. Based on these results, valerian, lavender, and chamomile oils were mixed in different ratios to produce blending oils A (L:C:V=2:2:1), B (L:C:V=3:1:1) and C (L:C:V=1:3:1). The highest level of serum 5-hydroxytryptamine was observed after administering blending oil A. These results suggest that blending oil A might possess therapeutic effects against insomnia. Overall, it is hypothesized that the optimally blended essential oil will produce synergic effects when combined with hypnotic drugs.

THE EFFECT OF GINSENG ON BLOOD PRESSURE IN SPONTANEOUSLY HYPERTENSIVE RAT AND ESSENTIAL HYPERTENSION

  • Sohn E. Suk;Huh Bong Yul;Park Seong Chul;Park Chan Woong;Kim Hae Jung
    • Proceedings of the Ginseng society Conference
    • /
    • 1980.09a
    • /
    • pp.1-3
    • /
    • 1980
  • To investigate the effect of ginseng on blood pressure (B.P.) in spontaneously hypertensive rat (SHR) and essential hypertension ginseng extract was given per se daily in 58 SHR and 35 essential hypertensive patients. SHR were divided into 5 groups according to the dosage of ginseng. In essential hypertension 1,000mg of ginseng extract was given. The B.P. in SHR was measured by tail cuff method. In essential hypertension side effect and changes in various laboratory examinations were evaluated. In SHR ginseng appeared to have hypertensive effect when it is given in small amount(10mg/kg). However, when it is given 60mg/kg/day or more difinite B.P. lowering effect was observed. The hypotensive effect was dosedependant and it lasted for 37days of observation. In essential hypertension in 12 $(80\%)$ among 15 patients hypotensive effect was seen with ginseng administration along and the effect lasted for 12 weeks. In the rest of hypertensive patients it is required addition of diuretics of other antihypertensive drugs to decrease B.P., no appreciable side effect was seen. In laboratory examinations no significant changes were seen except for serum cholesterol, ${\alpha}-and\;{\beta}-lipoprotein,$ and hematocrit. There was some evidence of relationship between plasma renin activity (PRA) and ginseng in hypotensive action.

  • PDF

Antimicrobial Activity of Basil, Oregano, and Thyme Essential Oils

  • Sakkas, Hercules;Papadopoulou, Chrissanthy
    • Journal of Microbiology and Biotechnology
    • /
    • v.27 no.3
    • /
    • pp.429-438
    • /
    • 2017
  • For centuries, plants have been used for a wide variety of purposes, from treating infectious diseases to food preservation and perfume production. Presently, the increasing resistance of microorganisms to currently used antimicrobials in combination with the appearance of emerging diseases requires the urgent development of new, more effective drugs. Plants, due to the large biological and structural diversity of their components, constitute a unique and renewable source for the discovery of new antibacterial, antifungal, and antiparasitic compounds. In the present paper, the history, composition, and antimicrobial activities of the basil, oregano, and thyme essential oils are reviewed.